Log in
Enquire now
‌

US Patent 8140270 Methods and systems for medical sequencing analysis

Patent 8140270 was granted and assigned to National Center for Genome Resources on March, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
‌
National Center for Genome Resources
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
81402700
Patent Inventor Names
Gregory D. May0
Damian D. G. Gessler0
Joann Mudge0
Stephen F. Kingsmore0
Date of Patent
March 20, 2012
0
Patent Application Number
120540720
Date Filed
March 24, 2008
0
Patent Citations Received
‌
US Patent 12071669 Methods and systems for detection of abnormal karyotypes
0
‌
US Patent 11753686 Methods for using mosaicism in nucleic acids sampled distal to their origin
‌
US Patent 11976326 Methods and systems for genetic analysis
0
‌
US Patent 12084717 Methods and systems for genetic analysis
0
‌
US Patent 11935625 Methods and systems for genomic analysis
0
‌
US Patent 11952625 Methods and systems for genetic analysis
0
‌
US Patent 11965214 Methods for using mosaicism in nucleic acids sampled distal to their origin
0
‌
US Patent 11920202 Unbiased identification of tumor rejection mediating neoepitopes
0
Patent Primary Examiner
‌
Lori A. Clow
0
Patent abstract

Disclosed are methods of identifying elements associated with a trait, such as a disease. The methods can comprise, for example, identifying the association of a relevant element (such as a genetic variant) with a relevant component phenotype (such as a disease symptom) of the trait, wherein the association of the relevant element with the relevant component phenotype identifies the relevant element as an element associated with the trait, wherein the relevant component phenotype is a component phenotype having a threshold value of severity, age of onset, specificity to the trait or disease, or a combination, wherein the relevant element is an element having a threshold value of importance of the element to homeostasis relevant to the trait, intensity of the perturbation of the element, duration of the effect of the element, or a combination. The disclosed methods are based on a model of how elements affect complex diseases. The disclosed model is based on the existence of significant genetic and environmental heterogeneity in complex diseases. Thus, the specific combinations of genetic and environmental elements that cause disease vary widely among the affected individuals in a cohort. The disclosed model is an effective, general experimental design and analysis approach for the identification of causal variants in common, complex diseases by medical sequencing. The disclosed model and the disclosed methods based on the model can be used to generate valuable and useful information.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8140270 Methods and systems for medical sequencing analysis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.